Table 2.
Comparison of Percentage of Providers Meeting Primary Care Performance Measures by Gender
| Quality measures | Eligible patients | Male provider | Female provider | Adjusted p value* |
|---|---|---|---|---|
| Composite outcome (SD) | 241,428 | 75.8% (5.6) | 76.6% (5.3) | 0.17 |
| Cancer screening | ||||
| Colorectal CA screen (SD) | 120,894 | 73.2% (11.6) | 73.0% (12.2) | 0.76 |
| Mammogram screen age 52–74 (SD) | 9993 | 83.7% (19.8) | 79.4% (16.2) | 0.44 |
| Mammogram screen age 40+ (SD) | 7677 | 73.8% (21.7) | 69.3% (17.4) | 0.36 |
| Cervical cancer screening (SD) | 12,377 | 73.5% (22.5) | 72.3% (18.2) | 0.66 |
| Cardiovascular care | ||||
| Abdominal aortic aneurysm screening (SD) | 49,821 | 79.7% (15.6) | 79.5% (15.9) | 0.60 |
| CVD on moderate-dose statin (SD) | 35,792 | 75.4% (13.1) | 74.2% (12.9) | 0.55 |
| History of myocardial infarction (SD) | ||||
| On ASA | 6723 | 88.2% (16.1) | 88.6% (13.1) | 0.60 |
| On beta-blocker | 6723 | 86.3% (14.4) | 87.0% (13.7) | 0.79 |
| CHF on ACE I or ARB (SD) | 8273 | 83.6% (16.5) | 82.6 (15.3) | 0.41 |
| HTN BP < 139/89 age 18–59 (SD) | 58,573 | 64.2% (12.0) | 66.0% (11.2) | 0.32 |
| HTN BP < 149/89 age 60–85 (SD) | 68,759 | 80.6% (7.3) | 81.2% (7.6) | 0.99 |
| HTN BP < 149/89 (all ages) (SD) | 127,332 | 77.2% (8.3) | 77.1% (8.1) | 0.89 |
| Diabetes care | ||||
| BP < 140/90 (SD) | 43,292 |
72.4% (9.4) |
72.7% (9.0) | 0.67 |
| HbA1c ≤ 9 (SD) | 43,203 |
78.6% (9.3) |
80.0% (9.0) | 0.12 |
| A1C at goal (SD) | 60,118 | 86.1% (15.9) | 88.0% (13.7) | 0.50 |
| Hypoglycemia screen performed (SD) | 7848 | 84.0% (18.6) | 87.7% (15.2) | 0.006 |
| On moderate-dose statin (SD) | 26,137 | 72.9% (13.7) | 70.0% (12.1) | 0.09 |
| Retinal exam performed (SD) | 43,291 | 76.4% (13.7) | 77.3% (12.0) | 0.15 |
| Diabetic foot risk (SD) | 63,823 | 58.9% (22.1) | 62.6% (19.5) | 0.29 |
| Podiatry referral (SD) | 6820 | 82.7% (19.9) | 79.2% (19.7) | 0.50 |
| Lifestyle screening | ||||
| Alcohol screening performed (SD) | 206,302 | 93.2% (3.9) | 93.6% (3.5) | 0.68 |
| Alcohol F/U positive screen (SD) | 16,947 | 78.9% (20.7) | 81.6% (16.8) | 0.04 |
| Tobacco counseling performed (SD) | 45,220 | 90.0% (12.9) | 89.2% (11.5) | 0.37 |
| Immunizations | ||||
| Influenza (overall) (SD) | 241,428 | 45.2% (8.8) | 45.9% (11.6) | 0.25 |
| Influenza (18–64) (SD) | 97,639 | 34.8% (10.6) | 36.1% (15.4) | 0.08 |
| Influenza (> 65) (SD) | 138,958 | 52.9% (10.1) | 53.2% (11.5) | 0.40 |
| PPSV23 (SD) | 162,321 | 78.9% (13.4) | 77.0% (15.2) | 0.25 |
| PCV13 (SD) | 138,178 | 78.4% (12.9) | 78.8% (12.9) | 0.90 |
| Tdap (SD) | 241,428 | 67.3% (22.8) | 70.4% (20.7) | 0.33 |
| Opiate management | ||||
| Opioid urine screen (SD) | 7414 | 87.6% (14.3) | 88.4% (13/8_) | 0.31 |
| Opioid consent (SD) | 7414 | 91.4% (12.3) | 90.5% (13.4) | 0.78 |
| Continuity | ||||
| Visit < 18 months (SD) | 241,248 | 96.0% (2.5) | 96.5% (2.2) | 0.05 |
| Miscellaneous | ||||
| OEF/OIF post deploy screen (SD) | 25,031 | 88.0% (14.9) | 90.8% (12.8) | 0.18 |
| HIV testing offered (SD) | 236,141 | 75.1% (21.9) | 77.6% (21.9) | 0.94 |
*Adjusted for panel size, type of provider (MD vs. NP or PA), years since completion of training, status (staff vs. trainee), VA Center